The past 6 years since the first edition of this book have seen great progress in the development of genetically engineered mouse (GEM) models of cancer. These models are finding an important role in furthering our understanding of the biology of malignant disease. A comfortable position for GEM models in the routine conduct of screening for potential new therapeutics is coming more slowly but is coming. Increasing numbers of genetically engineered mice are available, some with conditional activation of oncogenes, some with multiple genetic changes providing mouse models that are moving closer to the human disease.
Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.
Dr. Beverly A. Teicher is Senior Scientific Director in Cancer Research at Genzyme Molecular Oncology and Genzyme Corporation, Framingham, Massachusetts. She has authored or co-authored more than 400 scientific publications, has edited five books, senior editor for the journal Clinical Cancer Research and is series editor for the Cancer Drug Discovery and Development book series.
Beverly A. Teicher and a panel of leading experts comprehensively describe the state-of-the-art in animal tumor model research. This volume updates and extends the comprehensive presentations in the first edition. The wide array of models detailed form the basis for the selection of compounds and treatments that go into clinical testing of patients, and include syngeneic models, human tumor xenograft models, orthotopic models, metastatic models, and genetically engineered mouse models. Synthesizing many years experience with all the major in vivo models currently available for the study of malignant disease, Tumor Models in Cancer Research 2nd edition, provides preclinical and clinical cancer researchers alike with a comprehensive guide to the selection of these models, their effective use, and the optimal interpretation of their results.
„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.
Anbieter: Salish Sea Books, Bellingham, WA, USA
Zustand: Good. 2. Good++; Hardcover; Withdrawn library copy with minimal library markings; Covers are clean and glossy with no library markings; Unblemished textblock edges; Library card pocket and stamp to the last endpaper; First endpapers and text pages are all bright and unmarked; The binding is tight with a straight spine;; Medium Format (8.5" - 9.75" tall); 3.3 lbs; Blue and orange covers with title in white lettering; 2nd Edition; 2010, Humana Publishing; 707 pages; "Tumor Models in Cancer Research (Cancer Drug Discovery and Development)," by Beverly A. Teicher. Artikel-Nr. SKU-1364AO01311262
Anzahl: 1 verfügbar
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
Zustand: New. In. Artikel-Nr. ria9781607619673_new
Anzahl: Mehr als 20 verfügbar
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
Hardcover. Zustand: Brand New. 2nd edition. edition. 693 pages. 9.50x6.50x2.00 inches. In Stock. Artikel-Nr. x-1607619679
Anzahl: 2 verfügbar
Anbieter: Kennys Bookstore, Olney, MD, USA
Zustand: New. Since the first edition of this book there has been great progress in the development of genetically engineered mouse (GEM) models of cancer. This revised and updated edition comprehensively describes the state-of-the-art in animal tumor model research. Editor(s): Teicher, Beverly A. Series: Cancer Drug Discovery and Development. Num Pages: 693 pages, 57 colour tables, biography. BIC Classification: MJCL; MMG. Category: (P) Professional & Vocational. Dimension: 235 x 155 x 40. Weight in Grams: 1218. . 2010. 2nd ed. 2011. Hardback. . . . . Books ship from the US and Ireland. Artikel-Nr. V9781607619673
Anzahl: 15 verfügbar